Hematology:
Myelodysplastic syndrome — Chemotherapy and immunotherapy. Treatment in Germany, Erlangen

 

Sort by:

University Hospital Erlangen

9/10 from 51 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Department of Hematology and Internal Oncology deals with the diagnosis and treatment of patients with disorders of the hematopoietic system, such as acute and chronic leukemia and malignant lymphomas, as well as malignant solid tumors (if chemotherapy or other systemic treatments are needed).


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Erlangen

Price 11482.00